Clinical trials
Observational Cardiomyopathy, Dilated trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Institute of Heart, Lung and Blood Vessel Diseases | 2 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 2 |
| AstraZeneca | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Guangdong Provincial People's Hospital | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Shandong Provincial Hospital | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Dilated | 10 |
| Cardiomyopathy, Hypertrophic | 4 |
| Arrhythmogenic Right Ventricular Dysplasia | 3 |
| Cardiomyopathy, Restrictive | 2 |
| Death, Sudden, Cardiac | 1 |
| Heart Failure | 1 |
| Myocardial Infarction | 1 |
| Myocarditis | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.